BIOMARIN PHARMACEUTICAL INC Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for December 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 3,000 | 38,970 | 64,500 | |
| Dec 29 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.73 | 2,000 | 177,462 | 227,157 | 229.2 K to 227.2 K (-0.87 %) |
| Dec 29 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.73 | 3,000 | 266,193 | 43,195 | 46.2 K to 43.2 K (-6.49 %) |
| Dec 29 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 3,000 | 38,970 | 46,195 | 43.2 K to 46.2 K (+6.95 %) |
| Dec 12 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 2,000 | 25,980 | 67,500 | |
| Dec 12 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.00 | 2,000 | 190,000 | 43,195 | 45.2 K to 43.2 K (-4.43 %) |
| Dec 12 2014 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 2,000 | 25,980 | 45,195 | 43.2 K to 45.2 K (+4.63 %) |
| Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 21.51 | 7,500 | 161,325 | 0 | |
| Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 89.90 | 7,500 | 674,225 | 21,400 | 28.9 K to 21.4 K (-25.95 %) |
| Dec 08 2014 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 21.51 | 7,500 | 161,325 | 28,900 | 21.4 K to 28.9 K (+35.05 %) |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Option Exercise | M | 38.59 | 12,000 | 463,080 | 12,502 | |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Sell | S | 91.01 | 12,000 | 1,092,161 | 31,590 | 43.6 K to 31.6 K (-27.53 %) |
| Dec 05 2014 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Buy | M | 38.59 | 12,000 | 463,080 | 43,590 | 31.6 K to 43.6 K (+37.99 %) |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 28.23 | 5,000 | 141,150 | 14,491 | |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 21.51 | 6,429 | 138,288 | 0 | |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Option Exercise | M | 14.39 | 521 | 7,497 | 0 | |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 91.82 | 5,000 | 459,100 | 4,593 | 9.6 K to 4.6 K (-52.12 %) |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 28.23 | 5,000 | 141,150 | 9,593 | 4.6 K to 9.6 K (+108.86 %) |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 90.25 | 6,950 | 627,238 | 4,593 | 11.5 K to 4.6 K (-60.21 %) |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 21.51 | 6,429 | 138,288 | 11,543 | 5.1 K to 11.5 K (+125.71 %) |
| Dec 03 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Buy | M | 14.39 | 521 | 7,497 | 5,114 | 4.6 K to 5.1 K (+11.34 %) |
| Dec 02 2014 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Sell | S | 88.97 | 3,400 | 302,508 | 4,593 | 8 K to 4.6 K (-42.54 %) |